Stada Group
Modris Kuzmans is an experienced executive in the pharmaceutical industry, currently serving as General Manager at STADA Group since November 2020. Prior to this role, Modris worked at Mylan from February 2015 to November 2020, where responsibilities included Head of Commercial and Marketing Excellence for Global Expansion Markets and General Manager for the Baltic States. Earlier experience includes General Manager for Abbott's Established Pharmaceuticals Division in the Baltic States from September 2012 to February 2015, Head of Sales and Marketing at Sandoz Latvia from April 2009 to September 2012, and Sales Director at sanofi-aventis Latvia from April 2008 to January 2009. Modris began a career in the industry as National Sales Manager at GSK Latvia from 2002 to 2008. Educational background includes a Bachelor of Science in International Economic Relations from The University of Latvia and a Doctor of Medicine degree from Rīga Stradiņš University, with a specialization as a surgeon.
This person is not in any teams
This person is not in any offices
Stada Group
14 followers
Stada Arzneimittel AG is a Germany-based holding company active in the pharmaceutical sector and healthcare market. The Company develops and markets products with off-patent active pharmaceutical ingredients. The Company’s primary business segments are Generics and Branded Products. The Generics segment comprises low-priced and active-ingredient products. The Branded Products segment focuses on multisource products accessible without active ingredient research, notably anti-enzymatic food intolerance drugs that are marketed by the subsidiary SCIOTEC Diagnostics Technologies. The Company's generic drugs are marketed by the Group subsidiary, STADApharm GmbH. Non-core activities of the Company encompass Commercial Business segment, which includes activities with primarily trading character such as wholesaling activities. The Company operates STADA Pharmaceuticals Australia Pty Ltd and STADA IT SOLUTIONS DOO as subsidiaries.